Resilience

Interested in learning more about our Technical Development Center in Boston, MA without committing the time and airline miles to visit in person? Check out our virtual tour! Take a virtual walk through our Boston site to receive an in-depth, interactive look at our facility and the services it has to offer. You’ll find a comprehensive pathway from development to drug substance manufacturing, all under one roof. With 4x 2KL single-use and 6x 2KL stainless bioreactors, we are prepared to support a variety of product types and scale-up needs for your next drug substance program. Take a tour today: https://hubs.ly/Q02L6HxJ0

Picture a supply chain that never lets you down - that’s the dream with Build Your Resilience™. From secured secondary sources and identified vendors to flexible term agreements and raw material vendor qualification, we help ensure your supply chain remains robust and reliable. Say goodbye to the nightmare of shortages and delays, and hello to materials on hand and complete method transfers. Utilizing our network of North American clinical and commercial GMP manufacturing sites, including four commercially licensed facilities, Build Your Resilience™ allows you to partner with a backup supplier that is big enough to partner on your boldest projects, but small enough to provide the kind of service and agility that you wouldn’t typically expect from a conventional CDMO. If you’re tired of supply chain nightmares, find out how to Build Your Resilience™: https://hubs.ly/Q02LgXYD0

We’re looking forward to meeting you at BioProcess International, part of Biotech Week Boston! Connect with the Resilience team September 23-26 at booth #906 to learn how we can support your next development or manufacturing program. Schedule a meeting with us today: https://hubs.ly/Q02LVTm30

The Resilience team closed out a successful first day at the 16th annual Bioprocessing Summit in Boston! If you haven’t had a chance yet, be sure to stop by booth #609 to speak with Megan Kosiba Vitrano, Debleena Dasgupta, and Wesley Tidball, MBA. They’re enjoying making new connections, seeing old colleagues, and are excited to share how the processes and platforms Resilience offers help make novel therapies quickly, safely, and at scale right here in North America. There’s still time to schedule a meeting with us: https://hubs.ly/Q02LZqws0

Home to our Development and Manufacturing Center for Biologics and Vaccines, our Alachua site is answering the call to revolutionize how medicines are made, funded, and scaled. Alachua houses process development, scale up, and cGMP manufacturing capabilities for vaccines, biologics, and plasmids. It also features specialty capabilities in cell line management, including mammalian, microbial, insect cells, single-use bioreactors up to 2000L, and small batch fill/ finish. Interested in learning more? Experience our Alachua, Florida site in a whole new way, at your own speed and at your fingertips, today with a virtual tour: https://hubs.ly/Q02L6Mk80 

Tomorrow, during the 16th Annual Bioprocessing Summit, join Gilad Doron, Ph.D., for an exciting presentation focused on Improving cell line development in CHO with a focus on product manufacturability. In his presentation, Dr. Doron will focus on cell line selection, development, and manufacturing. He will also highlight productivity levels, selection based on cell specific productivity, benefits of utilizing molecular optimization and engineering, as well as Resilience’s cell-free protein platform, and more. We look forward to seeing you! Connect with us at the event: https://hubs.ly/Q02L6SBN0

As a multi-product and multiple modality facility with end-to-end services, our Toronto, Canada site is fully equipped to support the development and manufacturing of clinical and commercial products. With process and analytical development capabilities for vaccines, mAbs, small molecules, and more, flexible manufacturing up to 2000L, and formulation, filling, inspection, and labeling on site, our Toronto facility has built expertise in complex and commercial biopharmaceutical products. Learn more about our Toronto, Canada facility on a virtual tour today! Explore in an interactive 360 environment to see if Resilience could be the right fit for your next program: https://hubs.ly/Q02L6Ps50

We’re less than a week away from the 16th annual Bioprocessing Summit, September 19-22 in Boston. Meet Megan Kosiba Vitrano, Debleena Dasgupta, and Wesley Tidball at booth #609 to learn about the processes and platforms Resilience offers to make novel therapies quickly, safely, and at scale right here in North America.   Stop in for casual conversation or schedule a meeting with us: https://hubs.ly/Q02KPdhq0

Our RTP facility in North Carolina serves as a Center of Excellence for GMP Viral Vector Manufacturing. Designed to deliver best-in-class viral vector product manufacturing and testing for clinical through commercial use, the site specializes in the production of Adeno-associated virus (AAV) and Lentiviral vectors (LVV) drug substance (DS) and drug product fill/finish (DP) for in vivo and ex vivo applications. Interested in seeing it for yourself but can’t commit the time to traveling? Explore our RTP facility virtually! Take a virtual tour on your own time: https://hubs.ly/Q02LrDz00

Looking to build a robust and scalable development process for your oncolytic virus? Our team of experts are ready to help shape your advanced viral expansion strategies using suspension and adherent cell bioreactor technologies. Your innovation deserves innovative technologies and platforms to boost your viral yield. Learn more about how Resilience can support your process today: https://hubs.ly/Q02G3HCn0 #vaccines #vaccinedevelopment #oncolyticvirus #potencyassay #PAD